Paul Edward Kelly
Chief Operating Officer at Relmada Therapeutics · 1 reported transaction in 1 company · latest trade Nov 5, 2025
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +199.6%, S&P 500 +6.1% over the same days.
Their trades
Bought | Nov 5, 2025 | Nov 5, 2025 close $2.51 → Oct 23, 2026 close $3.27. S&P 500 +12.2% over the same days. |
BoughtRelmada Therapeutics
$198K
Nov 5, 2025 close $2.51 → Oct 23, 2026 close $3.27. S&P 500 +12.2% over the same days.